HAYWARD, Calif., November 14, 2023–Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing …
HAYWARD, Calif., November 14, 2023–Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing …
In